Capital International Investors Purchases New Shares in Cardinal Health, Inc. $CAH

Capital International Investors purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, Holdings Channel.com reports. The firm purchased 472,416 shares of the company’s stock, valued at approximately $97,081,000.

A number of other institutional investors have also made changes to their positions in the business. Redhawk Wealth Advisors Inc. raised its holdings in shares of Cardinal Health by 0.5% in the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after buying an additional 48 shares during the last quarter. HF Advisory Group LLC raised its holdings in shares of Cardinal Health by 0.9% in the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after buying an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. raised its holdings in shares of Cardinal Health by 0.9% in the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after buying an additional 50 shares during the last quarter. Generali Asset Management SPA SGR raised its holdings in shares of Cardinal Health by 11.0% in the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after buying an additional 51 shares during the last quarter. Finally, Stephens Inc. AR raised its holdings in shares of Cardinal Health by 0.9% in the fourth quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock valued at $1,223,000 after buying an additional 52 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Down 0.6%

Cardinal Health stock opened at $204.56 on Tuesday. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The business’s 50-day simple moving average is $202.47 and its 200 day simple moving average is $208.57. The stock has a market cap of $47.91 billion, a price-to-earnings ratio of 31.28, a P/E/G ratio of 1.12 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the firm posted $2.35 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 1.0%. Cardinal Health’s payout ratio is currently 31.19%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CAH. Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Evercore decreased their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Robert W. Baird set a $248.00 price target on Cardinal Health in a report on Friday, May 1st. JPMorgan Chase & Co. decreased their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Finally, Wells Fargo & Company decreased their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.